id,text,date,source,clean,compound,sentiment,month
news_0,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-09-12,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-09
news_1,"New research suggests Ozempic may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-03-18,news,new research suggests ozempic may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-03
news_2,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-08-26,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-08
news_3,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-10-21,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-10
news_4,New study finds Wegovy leads to average 16.9% body weight reduction in clinical trial involving 3790 participants. Researchers at Cleveland Clinic report significant improvements in cardiovascular outcomes alongside weight loss.,2024-08-05,news,new study find wegovy lead average body weight reduction clinical trial involving participant researcher cleveland clinic report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-08
news_5,"Economic analysis shows Wegovy could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-02-27,news,economic analysis show wegovy could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-02
news_6,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-04-11,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-04
news_7,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-08-23,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-08
news_8,"Counterfeit Wegovy found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-05-30,news,counterfeit wegovy found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-05
news_9,"Telehealth platforms make it easier than ever to get Ozempic prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-09-29,news,telehealth platform make easier ever get ozempic prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-09
news_10,"Celebrity endorsements drive surge in Ozempic prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-08-08,news,celebrity endorsement drive surge ozempic prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-08
news_11,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-02-09,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-02
news_12,"Wall Street analysts project Ozempic sales to reach $17 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-06-21,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-06
news_13,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-02-29,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-02
news_14,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-07-10,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-07
news_15,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-11-05,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-11
news_16,"Counterfeit Wegovy found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-05-20,news,counterfeit wegovy found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-05
news_17,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-12-30,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-12
news_18,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-06-24,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-06
news_19,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-12-10,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-12
news_20,The FDA has expanded the approved use of Wegovy for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-02-12,news,fda expanded approved use wegovy chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-02
news_21,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-03-20,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-03
news_22,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-05-25,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-05
news_23,Global demand for Ozempic outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-02-19,news,global demand ozempic outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-02
news_24,Concerns raised about long-term safety of GLP-1 receptor agonists like Ozempic. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-10-08,news,concern raised longterm safety glp receptor agonist like ozempic panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-10
news_25,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-12-06,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-12
news_26,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-03-21,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-03
news_27,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-07-15,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-07
news_28,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-11-02,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-11
news_29,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-07-08,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-07
news_30,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-03-30,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-03
news_31,"Wall Street analysts project Wegovy sales to reach $29 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-05-05,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-05
news_32,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-03-22,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-03
news_33,New study finds Ozempic leads to average 19.5% body weight reduction in clinical trial involving 3828 participants. Researchers at Stanford Medicine report significant improvements in cardiovascular outcomes alongside weight loss.,2024-02-06,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher stanford medicine report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-02
news_34,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-05-29,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-05
news_35,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-02-23,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-02
news_36,"Celebrity endorsements drive surge in Ozempic prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-04-17,news,celebrity endorsement drive surge ozempic prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-04
news_37,Novo Nordisk reports Wegovy shortage easing as production capacity increases. The pharmaceutical company has invested $6.5 billion in new manufacturing facilities to meet unprecedented demand.,2024-05-31,news,novo nordisk report wegovy shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-05
news_38,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-03-16,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-03
news_39,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-10-17,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-10
news_40,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-07-15,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-07
news_41,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-09-17,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-09
news_42,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-09-24,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-09
news_43,"Celebrity endorsements drive surge in Wegovy prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-01-08,news,celebrity endorsement drive surge wegovy prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-01
news_44,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-11-28,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-11
news_45,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-07-05,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-07
news_46,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-01-29,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-01
news_47,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-03-31,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-03
news_48,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-09-24,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-09
news_49,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-06-12,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-06
news_50,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-11-02,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-11
news_51,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-10-28,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-10
news_52,New study finds Wegovy leads to average 14.5% body weight reduction in clinical trial involving 3835 participants. Researchers at Stanford Medicine report significant improvements in cardiovascular outcomes alongside weight loss.,2024-06-17,news,new study find wegovy lead average body weight reduction clinical trial involving participant researcher stanford medicine report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-06
news_53,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-11-16,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-11
news_54,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-02-03,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-02
news_55,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-04-09,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-04
news_56,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-02-22,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-02
news_57,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-03-28,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-03
news_58,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-04-27,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-04
news_59,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-08-18,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-08
news_60,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-11-26,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-11
news_61,"Counterfeit Wegovy found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-05-30,news,counterfeit wegovy found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-05
news_62,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-04-20,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-04
news_63,"Counterfeit Wegovy found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-10-30,news,counterfeit wegovy found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-10
news_64,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-05-21,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-05
news_65,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-03-18,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-03
news_66,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-10-12,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-10
news_67,"Wall Street analysts project Ozempic sales to reach $26 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-08-16,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-08
news_68,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-05-10,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-05
news_69,Concerns raised about long-term safety of GLP-1 receptor agonists like Ozempic. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-09-27,news,concern raised longterm safety glp receptor agonist like ozempic panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-09
news_70,New study finds Wegovy leads to average 17.7% body weight reduction in clinical trial involving 762 participants. Researchers at Stanford Medicine report significant improvements in cardiovascular outcomes alongside weight loss.,2024-10-02,news,new study find wegovy lead average body weight reduction clinical trial involving participant researcher stanford medicine report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-10
news_71,Novo Nordisk reports Wegovy shortage easing as production capacity increases. The pharmaceutical company has invested $6.7 billion in new manufacturing facilities to meet unprecedented demand.,2024-09-19,news,novo nordisk report wegovy shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-09
news_72,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-05-21,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-05
news_73,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-01-11,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-01
news_74,New study finds Wegovy leads to average 18.2% body weight reduction in clinical trial involving 3694 participants. Researchers at Harvard Medical School report significant improvements in cardiovascular outcomes alongside weight loss.,2024-08-06,news,new study find wegovy lead average body weight reduction clinical trial involving participant researcher harvard medical school report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-08
news_75,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-10-21,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-10
news_76,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-09-30,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-09
news_77,"Social media influencers fuel Ozempic trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-12-02,news,social medium influencers fuel ozempic trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-12
news_78,"Celebrity endorsements drive surge in Wegovy prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-06-30,news,celebrity endorsement drive surge wegovy prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-06
news_79,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-07-13,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-07
news_80,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-03-30,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-03
news_81,"Celebrity endorsements drive surge in Ozempic prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-06-11,news,celebrity endorsement drive surge ozempic prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-06
news_82,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $3.5 billion in new manufacturing facilities to meet unprecedented demand.,2024-08-21,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-08
news_83,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-02-03,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-02
news_84,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $2.1 billion in new manufacturing facilities to meet unprecedented demand.,2024-11-27,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-11
news_85,"Wall Street analysts project Ozempic sales to reach $19 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-03-12,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-03
news_86,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-03-21,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-03
news_87,"Economic analysis shows Ozempic could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-03-24,news,economic analysis show ozempic could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-03
news_88,"New research suggests Ozempic may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-01-14,news,new research suggests ozempic may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-01
news_89,The FDA has expanded the approved use of Wegovy for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-11-02,news,fda expanded approved use wegovy chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-11
news_90,"Celebrity endorsements drive surge in Ozempic prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-02-27,news,celebrity endorsement drive surge ozempic prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-02
news_91,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-03-06,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-03
news_92,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-03-05,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-03
news_93,"Wall Street analysts project Ozempic sales to reach $24 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-11-10,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-11
news_94,"Counterfeit Ozempic found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-12-08,news,counterfeit ozempic found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-12
news_95,"Wall Street analysts project Wegovy sales to reach $16 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-07-16,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-07
news_96,"Celebrity endorsements drive surge in Ozempic prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-01-06,news,celebrity endorsement drive surge ozempic prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-01
news_97,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-11-14,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-11
news_98,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-05-10,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-05
news_99,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-08-06,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-08
news_100,Concerns raised about long-term safety of GLP-1 receptor agonists like Ozempic. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-03-05,news,concern raised longterm safety glp receptor agonist like ozempic panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-03
news_101,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-03-13,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-03
news_102,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-10-15,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-10
news_103,"Social media influencers fuel Ozempic trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-02-21,news,social medium influencers fuel ozempic trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-02
news_104,"Wall Street analysts project Ozempic sales to reach $27 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-05-31,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-05
news_105,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-12-28,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-12
news_106,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-03-14,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-03
news_107,Global demand for Ozempic outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-06-28,news,global demand ozempic outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-06
news_108,"Wall Street analysts project Wegovy sales to reach $19 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-04-15,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-04
news_109,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-11-17,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-11
news_110,"Telehealth platforms make it easier than ever to get Ozempic prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-03-19,news,telehealth platform make easier ever get ozempic prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-03
news_111,The FDA has expanded the approved use of Wegovy for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-10-26,news,fda expanded approved use wegovy chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-10
news_112,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-05-03,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-05
news_113,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-05-08,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-05
news_114,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-12-31,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-12
news_115,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-10-14,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-10
news_116,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-10-21,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-10
news_117,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-06-26,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-06
news_118,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-12-08,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-12
news_119,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-01-15,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-01
news_120,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-05-21,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-05
news_121,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-07-24,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-07
news_122,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-06-11,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-06
news_123,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $5.0 billion in new manufacturing facilities to meet unprecedented demand.,2024-07-14,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-07
news_124,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-06-14,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-06
news_125,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-07-22,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-07
news_126,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $2.9 billion in new manufacturing facilities to meet unprecedented demand.,2024-09-29,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-09
news_127,Global demand for Ozempic outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-06-14,news,global demand ozempic outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-06
news_128,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-05-05,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-05
news_129,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-08-12,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-08
news_130,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-05-13,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-05
news_131,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-12-20,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-12
news_132,"Social media influencers fuel Ozempic trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-02-23,news,social medium influencers fuel ozempic trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-02
news_133,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-08-23,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-08
news_134,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-06-26,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-06
news_135,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-12-31,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-12
news_136,"Wall Street analysts project Wegovy sales to reach $24 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-06-18,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-06
news_137,"Wall Street analysts project Wegovy sales to reach $16 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-12-30,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-12
news_138,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $6.4 billion in new manufacturing facilities to meet unprecedented demand.,2024-05-07,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-05
news_139,New study finds Ozempic leads to average 18.5% body weight reduction in clinical trial involving 4554 participants. Researchers at Harvard Medical School report significant improvements in cardiovascular outcomes alongside weight loss.,2024-07-25,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher harvard medical school report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-07
news_140,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-06-30,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-06
news_141,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-11-27,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-11
news_142,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-10-12,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-10
news_143,"Celebrity endorsements drive surge in Ozempic prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-06-05,news,celebrity endorsement drive surge ozempic prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-06
news_144,Novo Nordisk reports Wegovy shortage easing as production capacity increases. The pharmaceutical company has invested $5.0 billion in new manufacturing facilities to meet unprecedented demand.,2024-06-25,news,novo nordisk report wegovy shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-06
news_145,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-01-16,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-01
news_146,"New research suggests Ozempic may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-02-21,news,new research suggests ozempic may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-02
news_147,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-02-29,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-02
news_148,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-04-06,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-04
news_149,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-12-05,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-12
news_150,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-05-29,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-05
news_151,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-10-14,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-10
news_152,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-04-06,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-04
news_153,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-07-16,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-07
news_154,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-04-19,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-04
news_155,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-01-24,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-01
news_156,Concerns raised about long-term safety of GLP-1 receptor agonists like Ozempic. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-03-31,news,concern raised longterm safety glp receptor agonist like ozempic panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-03
news_157,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-08-04,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-08
news_158,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-07-30,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-07
news_159,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-03-06,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-03
news_160,Concerns raised about long-term safety of GLP-1 receptor agonists like Ozempic. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-03-26,news,concern raised longterm safety glp receptor agonist like ozempic panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-03
news_161,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-07-21,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-07
news_162,"Social media influencers fuel Ozempic trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-08-28,news,social medium influencers fuel ozempic trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-08
news_163,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-05-03,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-05
news_164,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-04-17,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-04
news_165,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-03-30,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-03
news_166,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-04-04,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-04
news_167,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-10-12,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-10
news_168,The FDA has expanded the approved use of Wegovy for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-11-12,news,fda expanded approved use wegovy chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-11
news_169,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-10-15,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-10
news_170,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-11-28,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-11
news_171,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-12-15,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-12
news_172,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-08-20,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-08
news_173,"Wall Street analysts project Ozempic sales to reach $20 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-07-07,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-07
news_174,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-07-24,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-07
news_175,Global demand for Ozempic outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-07-17,news,global demand ozempic outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-07
news_176,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-12-30,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-12
news_177,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-07-10,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-07
news_178,Global demand for Ozempic outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-11-15,news,global demand ozempic outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-11
news_179,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-04-02,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-04
news_180,Global demand for Ozempic outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-11-24,news,global demand ozempic outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-11
news_181,"Wall Street analysts project Ozempic sales to reach $19 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-09-06,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-09
news_182,Concerns raised about long-term safety of GLP-1 receptor agonists like Ozempic. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-06-18,news,concern raised longterm safety glp receptor agonist like ozempic panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-06
news_183,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-07-04,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-07
news_184,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-03-18,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-03
news_185,"Social media influencers fuel Ozempic trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-12-24,news,social medium influencers fuel ozempic trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-12
news_186,"Wall Street analysts project Ozempic sales to reach $27 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-08-30,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-08
news_187,New study finds Ozempic leads to average 17.9% body weight reduction in clinical trial involving 3468 participants. Researchers at Cleveland Clinic report significant improvements in cardiovascular outcomes alongside weight loss.,2024-08-17,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher cleveland clinic report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-08
news_188,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-03-31,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-03
news_189,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-05-29,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-05
news_190,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-03-27,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-03
news_191,"Economic analysis shows Ozempic could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-01-27,news,economic analysis show ozempic could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-01
news_192,"Counterfeit Wegovy found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-12-03,news,counterfeit wegovy found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-12
news_193,"Wall Street analysts project Ozempic sales to reach $27 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-04-12,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-04
news_194,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-07-27,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-07
news_195,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-08-18,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-08
news_196,"Economic analysis shows Wegovy could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-05-04,news,economic analysis show wegovy could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-05
news_197,Novo Nordisk reports Wegovy shortage easing as production capacity increases. The pharmaceutical company has invested $7.2 billion in new manufacturing facilities to meet unprecedented demand.,2024-01-07,news,novo nordisk report wegovy shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-01
news_198,"Wall Street analysts project Ozempic sales to reach $18 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-11-09,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-11
news_199,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-01-02,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-01
news_200,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-08-31,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-08
news_201,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-08-14,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-08
news_202,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $2.9 billion in new manufacturing facilities to meet unprecedented demand.,2024-12-24,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-12
news_203,"Celebrity endorsements drive surge in Ozempic prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-11-03,news,celebrity endorsement drive surge ozempic prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-11
news_204,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-05-24,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-05
news_205,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-02-10,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-02
news_206,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $6.1 billion in new manufacturing facilities to meet unprecedented demand.,2024-10-18,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-10
news_207,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-06-09,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-06
news_208,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-06-15,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-06
news_209,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-03-12,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-03
news_210,"Wall Street analysts project Wegovy sales to reach $20 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-03-18,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-03
news_211,Concerns raised about long-term safety of GLP-1 receptor agonists like Ozempic. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-01-12,news,concern raised longterm safety glp receptor agonist like ozempic panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-01
news_212,"New research suggests Ozempic may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-11-06,news,new research suggests ozempic may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-11
news_213,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-06-29,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-06
news_214,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-04-20,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-04
news_215,"New research suggests Ozempic may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-11-09,news,new research suggests ozempic may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-11
news_216,"Economic analysis shows Ozempic could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-02-02,news,economic analysis show ozempic could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-02
news_217,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-11-20,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-11
news_218,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-11-19,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-11
news_219,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-07-15,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-07
news_220,Novo Nordisk reports Wegovy shortage easing as production capacity increases. The pharmaceutical company has invested $7.4 billion in new manufacturing facilities to meet unprecedented demand.,2024-02-04,news,novo nordisk report wegovy shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-02
news_221,"Counterfeit Ozempic found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-11-20,news,counterfeit ozempic found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-11
news_222,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-06-09,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-06
news_223,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-09-25,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-09
news_224,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-03-14,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-03
news_225,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-10-11,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-10
news_226,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-05-25,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-05
news_227,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-07-07,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-07
news_228,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-11-09,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-11
news_229,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-09-11,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-09
news_230,"Wall Street analysts project Ozempic sales to reach $26 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-07-01,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-07
news_231,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-11-24,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-11
news_232,"Social media influencers fuel Ozempic trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-04-26,news,social medium influencers fuel ozempic trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-04
news_233,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-04-29,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-04
news_234,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-09-09,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-09
news_235,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-01-04,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-01
news_236,"Economic analysis shows Wegovy could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-11-17,news,economic analysis show wegovy could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-11
news_237,"Counterfeit Wegovy found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-11-07,news,counterfeit wegovy found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-11
news_238,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-01-15,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-01
news_239,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-04-12,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-04
news_240,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-10-17,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-10
news_241,"Economic analysis shows Ozempic could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-04-15,news,economic analysis show ozempic could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-04
news_242,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-12-07,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-12
news_243,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-05-20,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-05
news_244,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-11-26,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-11
news_245,Novo Nordisk reports Wegovy shortage easing as production capacity increases. The pharmaceutical company has invested $6.6 billion in new manufacturing facilities to meet unprecedented demand.,2024-06-03,news,novo nordisk report wegovy shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-06
news_246,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-02-14,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-02
news_247,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-02-02,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-02
news_248,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $2.2 billion in new manufacturing facilities to meet unprecedented demand.,2024-08-26,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-08
news_249,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-04-13,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-04
news_250,"Counterfeit Ozempic found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-11-28,news,counterfeit ozempic found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-11
news_251,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-05-26,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-05
news_252,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-10-09,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-10
news_253,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-05-29,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-05
news_254,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-06-19,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-06
news_255,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-11-02,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-11
news_256,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-02-27,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-02
news_257,"Economic analysis shows Ozempic could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-04-26,news,economic analysis show ozempic could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-04
news_258,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-04-22,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-04
news_259,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-01-01,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-01
news_260,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-06-04,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-06
news_261,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-12-14,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-12
news_262,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-12-23,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-12
news_263,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-11-21,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-11
news_264,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-12-24,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-12
news_265,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-01-20,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-01
news_266,"Counterfeit Wegovy found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-08-20,news,counterfeit wegovy found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-08
news_267,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-04-20,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-04
news_268,New study finds Ozempic leads to average 18.8% body weight reduction in clinical trial involving 731 participants. Researchers at Stanford Medicine report significant improvements in cardiovascular outcomes alongside weight loss.,2024-08-25,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher stanford medicine report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-08
news_269,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-03-30,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-03
news_270,"Celebrity endorsements drive surge in Wegovy prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-02-09,news,celebrity endorsement drive surge wegovy prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-02
news_271,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-04-24,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-04
news_272,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-11-05,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-11
news_273,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-11-21,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-11
news_274,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-02-03,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-02
news_275,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-02-14,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-02
news_276,"Telehealth platforms make it easier than ever to get Ozempic prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-02-04,news,telehealth platform make easier ever get ozempic prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-02
news_277,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-12-25,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-12
news_278,The FDA has expanded the approved use of Wegovy for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-10-26,news,fda expanded approved use wegovy chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-10
news_279,"Wall Street analysts project Wegovy sales to reach $21 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-12-05,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-12
news_280,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-03-15,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-03
news_281,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $3.0 billion in new manufacturing facilities to meet unprecedented demand.,2024-11-16,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-11
news_282,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-01-15,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-01
news_283,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-11-26,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-11
news_284,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-08-01,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-08
news_285,"Wall Street analysts project Ozempic sales to reach $23 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-08-25,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-08
news_286,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-12-18,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-12
news_287,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-05-08,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-05
news_288,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-05-02,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-05
news_289,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-05-15,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-05
news_290,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-12-30,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-12
news_291,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-11-22,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-11
news_292,"Celebrity endorsements drive surge in Wegovy prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-05-18,news,celebrity endorsement drive surge wegovy prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-05
news_293,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-07-11,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-07
news_294,New study finds Wegovy leads to average 12.7% body weight reduction in clinical trial involving 2587 participants. Researchers at Cleveland Clinic report significant improvements in cardiovascular outcomes alongside weight loss.,2024-09-18,news,new study find wegovy lead average body weight reduction clinical trial involving participant researcher cleveland clinic report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-09
news_295,"Counterfeit Ozempic found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-08-11,news,counterfeit ozempic found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-08
news_296,"Wall Street analysts project Ozempic sales to reach $17 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-05-22,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-05
news_297,"Wall Street analysts project Wegovy sales to reach $16 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-01-06,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-01
news_298,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-10-09,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-10
news_299,New study finds Ozempic leads to average 17.5% body weight reduction in clinical trial involving 3094 participants. Researchers at Mayo Clinic report significant improvements in cardiovascular outcomes alongside weight loss.,2024-04-14,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher mayo clinic report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-04
news_300,"Celebrity endorsements drive surge in Ozempic prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-07-27,news,celebrity endorsement drive surge ozempic prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-07
news_301,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-05-02,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-05
news_302,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-02-11,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-02
news_303,"Wall Street analysts project Wegovy sales to reach $15 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-10-04,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-10
news_304,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-09-16,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-09
news_305,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-03-27,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-03
news_306,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-04-28,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-04
news_307,New study finds Wegovy leads to average 18.9% body weight reduction in clinical trial involving 2499 participants. Researchers at Harvard Medical School report significant improvements in cardiovascular outcomes alongside weight loss.,2024-07-18,news,new study find wegovy lead average body weight reduction clinical trial involving participant researcher harvard medical school report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-07
news_308,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-08-11,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-08
news_309,"Counterfeit Ozempic found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-10-26,news,counterfeit ozempic found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-10
news_310,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-12-28,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-12
news_311,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-08-19,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-08
news_312,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-09-23,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-09
news_313,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-03-26,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-03
news_314,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-09-30,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-09
news_315,"Celebrity endorsements drive surge in Wegovy prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-03-28,news,celebrity endorsement drive surge wegovy prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-03
news_316,"Economic analysis shows Ozempic could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-08-28,news,economic analysis show ozempic could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-08
news_317,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-12-29,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-12
news_318,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-08-23,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-08
news_319,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-11-06,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-11
news_320,"Economic analysis shows Wegovy could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-01-19,news,economic analysis show wegovy could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-01
news_321,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-01-13,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-01
news_322,New study finds Ozempic leads to average 14.2% body weight reduction in clinical trial involving 1705 participants. Researchers at Cleveland Clinic report significant improvements in cardiovascular outcomes alongside weight loss.,2024-11-28,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher cleveland clinic report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-11
news_323,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-08-26,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-08
news_324,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-11-23,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-11
news_325,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-02-09,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-02
news_326,"Economic analysis shows Wegovy could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-04-09,news,economic analysis show wegovy could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-04
news_327,New study finds Ozempic leads to average 21.9% body weight reduction in clinical trial involving 1695 participants. Researchers at Stanford Medicine report significant improvements in cardiovascular outcomes alongside weight loss.,2024-09-17,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher stanford medicine report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-09
news_328,New study finds Wegovy leads to average 16.5% body weight reduction in clinical trial involving 3236 participants. Researchers at Stanford Medicine report significant improvements in cardiovascular outcomes alongside weight loss.,2024-05-25,news,new study find wegovy lead average body weight reduction clinical trial involving participant researcher stanford medicine report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-05
news_329,"Telehealth platforms make it easier than ever to get Ozempic prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-03-19,news,telehealth platform make easier ever get ozempic prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-03
news_330,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-02-17,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-02
news_331,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-04-09,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-04
news_332,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-04-17,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-04
news_333,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-12-10,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-12
news_334,"Telehealth platforms make it easier than ever to get Ozempic prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-08-28,news,telehealth platform make easier ever get ozempic prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-08
news_335,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-04-25,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-04
news_336,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-01-27,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-01
news_337,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-08-25,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-08
news_338,"Social media influencers fuel Ozempic trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-06-02,news,social medium influencers fuel ozempic trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-06
news_339,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-08-11,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-08
news_340,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-06-06,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-06
news_341,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-05-04,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-05
news_342,"Celebrity endorsements drive surge in Wegovy prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-01-05,news,celebrity endorsement drive surge wegovy prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-01
news_343,Pediatric obesity experts discuss potential role of Wegovy in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-01-17,news,pediatric obesity expert discus potential role wegovy treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-01
news_344,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-06-18,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-06
news_345,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-02-25,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-02
news_346,New competitor drugs challenge Wegovy dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-08-24,news,new competitor drug challenge wegovy dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-08
news_347,"Economic analysis shows Ozempic could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-12-06,news,economic analysis show ozempic could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-12
news_348,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-08-02,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-08
news_349,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-02-10,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-02
news_350,"Wall Street analysts project Ozempic sales to reach $17 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-05-24,news,wall street analyst project ozempic sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-05
news_351,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-12-29,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-12
news_352,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-05-09,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-05
news_353,"Telehealth platforms make it easier than ever to get Wegovy prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-12-28,news,telehealth platform make easier ever get wegovy prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-12
news_354,New study finds Ozempic leads to average 20.7% body weight reduction in clinical trial involving 1844 participants. Researchers at Johns Hopkins report significant improvements in cardiovascular outcomes alongside weight loss.,2024-06-20,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher john hopkins report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-06
news_355,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-08-01,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-08
news_356,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-09-13,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-09
news_357,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-08-10,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-08
news_358,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-01-10,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-01
news_359,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-06-10,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-06
news_360,"Telehealth platforms make it easier than ever to get Ozempic prescriptions, but critics warn about inadequate medical oversight and the risks of prescribing weight loss drugs without thorough evaluation.",2024-07-21,news,telehealth platform make easier ever get ozempic prescription critic warn inadequate medical oversight risk prescribing weight loss drug without thorough evaluation,-0.8922,negative,2024-07
news_361,The FDA has expanded the approved use of Ozempic for chronic weight management in adults with obesity. Health officials say the drug represents a major advancement in obesity treatment options.,2024-01-25,news,fda expanded approved use ozempic chronic weight management adult obesity health official say drug represents major advancement obesity treatment option,0.4215,positive,2024-01
news_362,New study finds Wegovy leads to average 17.0% body weight reduction in clinical trial involving 3008 participants. Researchers at Stanford Medicine report significant improvements in cardiovascular outcomes alongside weight loss.,2024-10-24,news,new study find wegovy lead average body weight reduction clinical trial involving participant researcher stanford medicine report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-10
news_363,Concerns raised about long-term safety of GLP-1 receptor agonists like Wegovy. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-10-06,news,concern raised longterm safety glp receptor agonist like wegovy panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-10
news_364,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-05-12,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-05
news_365,Wegovy manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-02-19,news,wegovy manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-02
news_366,"Social media influencers fuel Wegovy trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-01-02,news,social medium influencers fuel wegovy trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-01
news_367,"Celebrity endorsements drive surge in Wegovy prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-09-18,news,celebrity endorsement drive surge wegovy prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-09
news_368,Novo Nordisk reports Wegovy shortage easing as production capacity increases. The pharmaceutical company has invested $3.1 billion in new manufacturing facilities to meet unprecedented demand.,2024-10-06,news,novo nordisk report wegovy shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-10
news_369,Novo Nordisk reports Ozempic shortage easing as production capacity increases. The pharmaceutical company has invested $5.1 billion in new manufacturing facilities to meet unprecedented demand.,2024-09-02,news,novo nordisk report ozempic shortage easing production capacity increase pharmaceutical company invested billion new manufacturing facility meet unprecedented demand,-0.128,negative,2024-09
news_370,The rise of GLP-1 drugs like Ozempic is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-04-18,news,rise glp drug like ozempic reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-04
news_371,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-10-12,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-10
news_372,The rise of GLP-1 drugs like Wegovy is reshaping the food industry. Major food companies report declining snack sales as millions of Americans reduce caloric intake on these medications.,2024-01-02,news,rise glp drug like wegovy reshaping food industry major food company report declining snack sale million american reduce caloric intake medication,0.3612,positive,2024-01
news_373,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-02-13,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-02
news_374,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-03-02,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-03
news_375,Insurance companies increasingly covering Wegovy for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-01-29,news,insurance company increasingly covering wegovy weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-01
news_376,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-09-28,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-09
news_377,"New research suggests Wegovy may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-06-16,news,new research suggests wegovy may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-06
news_378,"Economic analysis shows Ozempic could save healthcare system billions by reducing obesity-related conditions including type 2 diabetes, hypertension, and joint replacement surgeries.",2024-06-19,news,economic analysis show ozempic could save healthcare system billion reducing obesityrelated condition including type diabetes hypertension joint replacement surgery,0.4939,positive,2024-06
news_379,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-10-08,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-10
news_380,"Social media influencers fuel Ozempic trend, posting dramatic before-and-after photos. Mental health experts express concern about unrealistic expectations and body image pressures.",2024-02-21,news,social medium influencers fuel ozempic trend posting dramatic beforeandafter photo mental health expert express concern unrealistic expectation body image pressure,-0.3182,negative,2024-02
news_381,"New research suggests Ozempic may have benefits beyond weight loss, including reduced risk of kidney disease, heart failure, and certain types of cancer. Scientists call findings 'promising but preliminary'.",2024-01-27,news,new research suggests ozempic may benefit beyond weight loss including reduced risk kidney disease heart failure certain type cancer scientist call finding promising preliminary,-0.431,negative,2024-01
news_382,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Ozempic, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-07-26,news,compounding pharmacy offer cheaper semaglutide alternative brandname ozempic sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-07
news_383,"Celebrity endorsements drive surge in Wegovy prescriptions for weight loss, raising ethical concerns among healthcare professionals about off-label use and medication shortages for diabetic patients.",2024-11-28,news,celebrity endorsement drive surge wegovy prescription weight loss raising ethical concern among healthcare professional offlabel use medication shortage diabetic patient,0.1027,positive,2024-11
news_384,New study finds Ozempic leads to average 16.7% body weight reduction in clinical trial involving 1537 participants. Researchers at Mayo Clinic report significant improvements in cardiovascular outcomes alongside weight loss.,2024-07-27,news,new study find ozempic lead average body weight reduction clinical trial involving participant researcher mayo clinic report significant improvement cardiovascular outcome alongside weight loss,0.2023,positive,2024-07
news_385,"Compounding pharmacies offer cheaper semaglutide alternatives to brand-name Wegovy, sparking debate about safety, efficacy, and FDA regulation of compounded medications.",2024-08-08,news,compounding pharmacy offer cheaper semaglutide alternative brandname wegovy sparking debate safety efficacy fda regulation compounded medication,0.4215,positive,2024-08
news_386,Wegovy covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-10-23,news,wegovy covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-10
news_387,New competitor drugs challenge Ozempic dominance in the GLP-1 market. Eli Lilly's tirzepatide shows comparable or superior weight loss results in head-to-head clinical trials.,2024-01-01,news,new competitor drug challenge ozempic dominance glp market eli lillys tirzepatide show comparable superior weight loss result headtohead clinical trial,0.5106,positive,2024-01
news_388,"Counterfeit Ozempic found in multiple states, prompting FDA warning. Authorities seize thousands of fake injection pens containing potentially dangerous substances from unauthorized sellers.",2024-03-08,news,counterfeit ozempic found multiple state prompting fda warning authority seize thousand fake injection pen containing potentially dangerous substance unauthorized seller,-0.8225,negative,2024-03
news_389,Insurance companies increasingly covering Ozempic for weight loss as evidence mounts for long-term health benefits including reduced cardiovascular risk and improved metabolic markers.,2024-05-21,news,insurance company increasingly covering ozempic weight loss evidence mount longterm health benefit including reduced cardiovascular risk improved metabolic marker,0.3182,positive,2024-05
news_390,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-08-16,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-08
news_391,Doctors debate whether patients should stay on Ozempic indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-08-15,news,doctor debate whether patient stay ozempic indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-08
news_392,Ozempic covered by Medicare for first time under new policy. Advocates say this represents a critical step in recognizing obesity as a chronic disease requiring medical treatment.,2024-08-11,news,ozempic covered medicare first time new policy advocate say represents critical step recognizing obesity chronic disease requiring medical treatment,-0.3182,negative,2024-08
news_393,Ozempic manufacturer faces lawsuits over alleged failure to warn about gastroparesis and other serious gastrointestinal side effects. Plaintiffs claim permanent digestive damage.,2024-04-14,news,ozempic manufacturer face lawsuit alleged failure warn gastroparesis serious gastrointestinal side effect plaintiff claim permanent digestive damage,-0.8316,negative,2024-04
news_394,"Wall Street analysts project Wegovy sales to reach $30 billion by 2025, making it one of the best-selling drugs in pharmaceutical history. Novo Nordisk stock hits all-time high.",2024-09-28,news,wall street analyst project wegovy sale reach billion making one bestselling drug pharmaceutical history novo nordisk stock hit alltime high,0.0258,neutral,2024-09
news_395,Doctors debate whether patients should stay on Wegovy indefinitely. Weight regain after discontinuation raises questions about the long-term treatment paradigm for obesity management.,2024-09-01,news,doctor debate whether patient stay wegovy indefinitely weight regain discontinuation raise question longterm treatment paradigm obesity management,0.0,neutral,2024-09
news_396,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-07-15,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-07
news_397,Concerns raised about long-term safety of GLP-1 receptor agonists like Ozempic. A panel of endocrinologists calls for more comprehensive post-market surveillance studies.,2024-05-19,news,concern raised longterm safety glp receptor agonist like ozempic panel endocrinologist call comprehensive postmarket surveillance study,0.7645,positive,2024-05
news_398,Global demand for Wegovy outstrips supply as countries beyond the US see rising obesity rates. WHO calls for equitable access to effective obesity treatments worldwide.,2024-05-05,news,global demand wegovy outstrips supply country beyond see rising obesity rate call equitable access effective obesity treatment worldwide,0.3818,positive,2024-05
news_399,Pediatric obesity experts discuss potential role of Ozempic in treating adolescent obesity after promising trial results show significant weight reduction in teenagers aged 12-17.,2024-12-19,news,pediatric obesity expert discus potential role ozempic treating adolescent obesity promising trial result show significant weight reduction teenager aged,0.5423,positive,2024-12
